'You disappointed us': Why is Canada opposing more transparency in drug prices?

By Kelly Crowe · CBC News

Pharma industry says high prices are necessary to cover costs. Some nations want to see the data

Image: L. Cipriani/WHO

Delegates to the World Health Assembly are expected to consider a transparency resolution demanding the pharmaceutical industry release confidential data about the costs of R&D, the outcomes of clinical trials and the actual prices that countries pay for drugs after secret negotiations and rebates.

Behind closed doors at the World Health Assembly (WHA) meeting in Geneva this week, health officials from around the world began hammering at the black box of secrecy surrounding the pharmaceutical industry.

More at CBC News